Biotech Distilled
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 1682 | Founded | a year ago | Last Issue | 2 days ago |
| Active | |||||
Read this Newsletter
biotechdistilled.substack.comLatest Issues
Distilled Pro: Verdict Changes — November 4, 2026
November 4, 2026
November 4, 2026
UPDATE: OnKure Therapeutics (OKUR) - The Q3 Checkpoint: Two Boxes Ticked, One Still Empty
OnKure’s Q3 10-Q shows no ATM sales and cash on plan, but the promised PIKture-01 data are still missing, and the filing now names single-source Chinese manufacturers.
This Substack is reader-supported. To receive new posts and support my...
UPDATE: Mineralys Therapeutics (MLYS) - The Patents Come Home, the Specialists Head for the Door
Q3 hands Mineralys full title to lorundrostat’s patents and more cash than expected, but RA’s board seat is leaving and Samsara has set up a plan to sell into the PDUFA.
This Substack is reader-supported. To receive new posts and support m...
UPDATE: X4 Pharmaceuticals (XFOR) - The Covenant Lands
The K2 loan terms are out: a ~$60M cash floor from October 2027, a $15M conversion right struck at today’s price, and a runway that now ends in Q1 2029.
This Substack is reader-supported. To receive new posts and support my work, consider...
UPDATE: Edgewise Therapeutics (EWTX) - Sold Before the Coin Landed
Servier’s GRAND CANYON miss mostly wipes out the near-term Becker milestone, and the first post-deal 10-Q lowers the cash floor. EDG-7500 now carries even more of the valuation.
This Substack is reader-supported. To receive new posts and s...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Biotech Distilled.
| Subscribers | Engagement | 76 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #40 |
Authors
The writers behind this newsletter.
PhD in Medicinal Chemistry. Senior Patent Agent. Extensive experience evaluating drug discovery programs — from molecular mechanism to clinical plausibility.
Frequently Asked Questions
How can I access the email archive for Biotech Distilled?
You can find recent issues that have been published by Biotech Distilled on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Biotech Distilled have?
To see how many people subscribe to Biotech Distilled, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Biotech Distilled?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biotech Distilled as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Biotech Distilled?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biotech Distilled using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Biotech Distilled?
Scroll up to where it says Related Newsletters to see other publications like Biotech Distilled. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Biotech Distilled?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.